Individualized nutritional intervention improves the nutritional status of liver cancer patients after transcatheter arterial chemoembolization

被引:0
作者
Sun, Qian [1 ,2 ]
Yu, Huixi [2 ,3 ]
You, Tao [1 ,2 ,4 ]
Zhang, Dong [2 ,3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Clin Nutr, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 2, Dept Intervent Med, Bldg 109,Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Wenzhou, Peoples R China
关键词
Liver cancer; TACE; Individualized; nutrition; intervention; Nutritional; status; Liver function; ESPEN GUIDELINES;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: to explore the effect of individualized nutritional intervention on the nutritional status of patients with liver cancer after transcatheter arterial chemoembolization (TACE). Methods: 56 patients who underwent TACE in our hospital from March 2022 to March 2023 were selected as the study subjects. The patients were randomly divided into a control group (28 cases) and an intervention group (28 cases). The control group received routine dietary intervention, while the intervention group received individualized nutritional intervention. We analyzed the body mass index (BMI), nutritional risk screening 2002 (NRS 2002), nutritional status, liver function status, and incidence of complications in two groups of patients before TACE, 3 days after TACE, and 1 month after TACE. Results: on the third day after TACE, the nutritional related indicators of both groups of patients showed a significantly decrease compared to those before TACE (p p < 0.05), while the majority of liver function indicators significantly increased (p p < 0.05). Compared with those at 3 days after TACE, the nutritional status of the intervention group patients significantly improved (p p < 0.05) and liver function indicators significantly decreased (p p < 0.05) 1 month after TACE. One month after TACE, all nutritional indicators in the intervention group were significantly higher than those in the control group (p p < 0.05), and AST was significantly lower than that in the control group (p p < 0.05). The incidence of gastrointestinal complications and electrolyte disorders in the intervention group were significantly lower than that in the control group (p p < 0.05). Conclusion: individualized nutritional intervention can effectively improve nutritional status, improve liver function, and reduce the incidence of postoperative complications in liver cancer patients after TACE. It was worth promoting.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 21 条
  • [1] ESPEN guidelines on nutrition in cancer patients
    Arends, Jann
    Bachmann, Patrick
    Baracos, Vickie
    Barthelemy, Nicole
    Bertz, Hartmut
    Bozzetti, Federico
    Fearon, Ken
    Huetterer, Elisabeth
    Isenring, Elizabeth
    Kaasa, Stein
    Krznaric, Zeljko
    Laird, Barry
    Larsson, Maria
    Laviano, Alessandro
    Muhlebach, Stefan
    Muscaritoli, Maurizio
    Oldervoll, Line
    Ravasco, Paula
    Solheim, Tora
    Strasser, Florian
    de van der Schueren, Marian
    Preiser, Jean-Charles
    [J]. CLINICAL NUTRITION, 2017, 36 (01) : 11 - 48
  • [2] Chen CL, 2021, Chinese and Foreign Medical Research, V19, P144
  • [3] Chinese Society of Parenteral and Enteral Nutrition (CSPEN), 2023, Zhonghua Yi Xue Za Zhi, V103, P946, DOI 10.3760/cma.j.cn112137-20221116-02407
  • [4] Duan ZP, 2019, Journal of Practical Hepatology, V22, P624
  • [5] Jin Z C, 2022, Zhonghua Gan Zang Bing Za Zhi, V30, P340, DOI 10.3760/cma.j.cn501113-20200609-00302
  • [6] ESPEN guidelines for nutrition screening 2002
    Kondrup, J
    Allison, SP
    Elia, M
    Vellas, B
    Plauth, M
    [J]. CLINICAL NUTRITION, 2003, 22 (04) : 415 - 421
  • [7] Li JY, 2021, Electronic Journal of Metabolism and Nutrition of Cancer, V8, P309
  • [8] Li P, 2021, Chinese Journal of General Practice, V19, P1087, DOI [10.16766/j.cnki.issn.1674-4152.001991, DOI 10.16766/J.CNKI.ISSN.1674-4152.001991]
  • [9] Circular RNA circDLC1 inhibits MMP1-mediated liver cancer via interaction with HuR
    Liu, Hailing
    Lan, Tian
    Li, Hui
    Xu, Lin
    Chen, Xing
    Liao, Haotian
    Chen, Xiangzheng
    Du, Jinpeng
    Cai, Yunshi
    Wang, Jinju
    Li, Xuefeng
    Huang, Jiwei
    Yuan, Kefei
    Zeng, Yong
    [J]. THERANOSTICS, 2021, 11 (03): : 1396 - 1411
  • [10] Lu Q, 2020, Journal of Clinical Hepatology, V36, P592, DOI [10.3969/j.issn.1001-5256.2020.03.024, DOI 10.3969/J.ISSN.1001-5256.2020.03.024]